Structures and free-energy landscapes of the wild type and mutants of the Abeta(21-30) peptide are determined by an interplay between intrapeptide electrostatic and hydrophobic interactions.
暂无分享,去创建一个
D Thirumalai | John E Straub | J. Straub | D. Thirumalai | B. Tarus | Bogdan Tarus | Devarajan Thirumalai | D. Thirumalai
[1] T. C. Hu,et al. Multi-Terminal Network Flows , 1961 .
[2] R. Tycko,et al. Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.
[3] D. Otzen,et al. Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] P. Lansbury,et al. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.
[5] J. Straub,et al. Probing the origins of increased activity of the E22Q "Dutch" mutant Alzheimer's beta-amyloid peptide. , 2001, Biophysical journal.
[6] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[7] D. Bashford,et al. Electrostatic calculations of the pKa values of ionizable groups in bacteriorhodopsin. , 1992, Journal of molecular biology.
[8] G. Ciccotti,et al. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .
[9] D. Selkoe,et al. Title Amyloid β-protein fibrillogenesis . Structure and biological activity of protofibrillar intermediates , 1999 .
[10] J. Straub,et al. Charge states rather than propensity for beta-structure determine enhanced fibrillogenesis in wild-type Alzheimer's beta-amyloid peptide compared to E22Q Dutch mutant. , 2002, Protein science : a publication of the Protein Society.
[11] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[12] K. Iwata,et al. The Alzheimer's peptide a beta adopts a collapsed coil structure in water. , 2000, Journal of structural biology.
[13] R. Leapman,et al. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. , 2002, Biochemistry.
[14] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[15] D. Teplow,et al. On the nucleation of amyloid β‐protein monomer folding , 2005 .
[16] D. Craik,et al. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? , 1998, Biochemistry.
[17] M. Karplus,et al. pKa's of ionizable groups in proteins: atomic detail from a continuum electrostatic model. , 1990, Biochemistry.
[18] Andrij Baumketner,et al. Structure of the 21–30 fragment of amyloid β‐protein , 2006 .
[19] C. Barrow,et al. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.
[20] Francesca Massi,et al. Structural and dynamical analysis of the hydration of the Alzheimer's β‐amyloid peptide , 2003, J. Comput. Chem..
[21] H. Stanley,et al. Folding events in the 21-30 region of amyloid β-protein (Aβ) studied in silico , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] A. D'Ursi,et al. Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain. , 2002, European journal of biochemistry.
[23] J. Straub,et al. Dynamics of Asp23-Lys28 salt-bridge formation in Abeta10-35 monomers. , 2006, Journal of the American Chemical Society.
[24] D. Eisenberg,et al. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. , 1984, Journal of molecular biology.
[25] K. Beyreuther,et al. Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease. , 1995, European journal of biochemistry.
[26] D. Thirumalai,et al. Emerging ideas on the molecular basis of protein and peptide aggregation. , 2003, Current opinion in structural biology.
[27] Christine Wurth,et al. Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis. , 2002, Journal of molecular biology.
[28] C. Dobson,et al. Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.
[29] M. Karplus,et al. Hidden complexity of free energy surfaces for peptide (protein) folding. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Straub,et al. Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution. , 2001, Biophysical journal.
[31] J. M. Scholtz,et al. The role of protein stability, solubility, and net charge in amyloid fibril formation , 2003, Protein science : a publication of the Protein Society.
[32] D. Selkoe,et al. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. , 1999, The Journal of biological chemistry.
[33] M. Kirkitadze,et al. Structure determination of micelle-like intermediates in amyloid β-protein fibril assembly by using small angle neutron scattering , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] Fabrizio Chiti,et al. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Reed,et al. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .
[36] M. Kirkitadze,et al. Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] Hoover,et al. Canonical dynamics: Equilibrium phase-space distributions. , 1985, Physical review. A, General physics.
[38] M. Kirkitadze,et al. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. , 2001, Journal of molecular biology.
[39] R. Stough. Solvent and mutation effects on the nucleation of amyloid-protein folding , 2005 .
[40] Yutaka Ishikawa,et al. Scientific Computing in Object-Oriented Parallel Environments , 1997, Lecture Notes in Computer Science.
[41] A. Roher,et al. Molecular modeling of the Abeta1-42 peptide from Alzheimer's disease. , 1998, Protein engineering.
[42] Alexander D. MacKerell,et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.
[43] Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[44] H. Shao,et al. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. , 1999, Journal of molecular biology.
[45] Donald Bashford,et al. An Object-Oriented Programming Suite for Electrostatic Effects in Biological Molecules , 1997, ISCOPE.
[46] B. Brooks,et al. Constant pressure molecular dynamics simulation: The Langevin piston method , 1995 .
[47] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[48] Christopher M. Dobson,et al. Kinetic partitioning of protein folding and aggregation , 2002, Nature Structural Biology.
[49] D. Selkoe,et al. Alzheimer's Disease: A Central Role for Amyloid , 1994, Journal of neuropathology and experimental neurology.
[50] R. Riek,et al. 3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .
[51] Francesca Massi,et al. Energy landscape theory for Alzheimer's amyloid β‐peptide fibril elongation , 2001 .
[52] G. Glenner,et al. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.
[53] H. Scheraga,et al. Global optimization of clusters, crystals, and biomolecules. , 1999, Science.
[54] M. Karplus,et al. The topology of multidimensional potential energy surfaces: Theory and application to peptide structure and kinetics , 1997 .
[55] J. Antosiewicz,et al. Empirical relationships between protein structure and carboxyl pKa values in proteins , 2002, Proteins.
[56] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[57] R. Leapman,et al. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[58] V. Uversky. Natively unfolded proteins: A point where biology waits for physics , 2002, Protein science : a publication of the Protein Society.
[59] Sergei V. Krivov,et al. Free energy disconnectivity graphs: Application to peptide models , 2002 .
[60] M. Karplus,et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .